|Bid||585.00 x 1100|
|Ask||750.00 x 1100|
|Day's range||579.66 - 596.45|
|52-week range||545.00 - 832.70|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||2.66|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Bio Rad's (BIO) strength in its key product lines across major geographic regions buoys optimism.
Investors are optimistic about Bio-Rad (BIO) owing to robust segmental performances and a rebound in non-COVID businesses.
Here is how Bio-Rad Laboratories (BIO) and Fullgent Genetics (FLGT) have performed compared to their sector so far this year.